bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Fig. S15 from Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors
Authors: Manuel Edwin R. , Chen Jeremy , D'Apuzzo Massimo , Lampa Melanie G. , Kaltcheva Teodora I. , Thompson Curtis B. , Ludwig Thomas , Chung Vincent , Diamond Don J.
Published: April 2023

Chromium release assay utilizing a range of PMN (effectors) against various tumor targets. Purified splenic PMN from treated mouse groups (n=3) were used in a 51Cr cytotoxicity assay. Tumor targets consisted of KPC (pancreatic cancer), 4T1 (breast cancer), and B16F10 (melanoma) which were co-incubated directly with effectors at indicated E:T ratios. Each E:T ratio with specific tumor targets were done in triplicate. Percent lysis within the PEGPH20/shIDO-ST group was compared to the PEGPH20/shScr-ST treated group at each E:T ratio using Student's t test. Data shown is representative of multiple experiments.
Supplementary Fig. S14 from Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors
Authors: Manuel Edwin R. , Chen Jeremy , D'Apuzzo Massimo , Lampa Melanie G. , Kaltcheva Teodora I. , Thompson Curtis B. , Ludwig Thomas , Chung Vincent , Diamond Don J.
Published: April 2023

Depletion of adaptive immunity. Mice with 14 day tumors were injected intraperitoneal with depleting antibody (CD4, CD8, NK, IgG: 200 ug/mouse; Gr1: 60 ug/mouse) against indicated immune subsets 24hr prior to treatment with PEGPH20/shIDO-ST. Depletion antibodies were re-administered every 3 days. IVIS data are presented as (A) luminescent images, (B) quantitatively for each individual animal (n=6) and (C) collectively from multiple experiments. Groups were euthanized when {greater than or equal to}1 mouse reached endpoint (see Materials and Methods). Combined data only represents time points for groups where the total number of mice was still 6 (n=6). Statistical analyses were also performed for time points under these same criteria. **p{less than or equal to}0.01, Student's t test.
Supplementary Methods from Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma
Authors: Derks Sarah , Nason Katie S. , Liao Xiaoyun , Stachler Matthew D. , Liu Kevin X. , Liu Jie Bin , Sicinska Ewa , Goldberg Michael S. , Freeman Gordon J. , Rodig Scott J. , Davison Jon M. , Bass Adam J.
Published: April 2023

Supplementary Methods
Supplementary Figure S2 from Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma
Authors: Derks Sarah , Nason Katie S. , Liao Xiaoyun , Stachler Matthew D. , Liu Kevin X. , Liu Jie Bin , Sicinska Ewa , Goldberg Michael S. , Freeman Gordon J. , Rodig Scott J. , Davison Jon M. , Bass Adam J.
Published: April 2023

PD-1 expression is associated with reduced survival.
Supplemental Material, Supplementary Figures 1 and 2, Supplemental Tables 1 - 8 from A Serum Protein Signature Associated with Outcome after Anti–PD-1 Therapy in Metastatic Melanoma
Authors: Weber Jeffrey S. , Sznol Mario , Sullivan Ryan J. , Blackmon Shauna , Boland Genevieve , Kluger Harriet M. , Halaban Ruth , Bacchiocchi Antonietta , Ascierto Paolo A. , Capone Mariaelena , Oliveira Carlos , Meyer Krista , Grigorieva Julia , Asmellash Senait G. , Roder Joanna , Roder Heinrich
Published: April 2023

Supplementary Figure 1: Schema of the hierarchical classifier development platform Supplementary Figure 2: Process for the simultaneous refinement of training class labels and classifier Supplementary Table 1: Association of Patient Characteristics with Test Classification Supplementary Table 2: Association of Test Classification with Immune Adverse Events Supplementary Table 3: Points in m/Z used to align the raster spectra Supplementary Table 4: m/Z regions used for coarse normalization Supplementary Table 5: m/Z regions used for finer normalization Supplementary Table 6: Points in m/Z used to align the spectra Supplementary Table 7: m/Z regions used for final normalization Supplementary Table 8: Lists of proteins/peptides included in each of the significantly associated biological function protein sets
supplemental Figures 1-5 from PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
Authors: Wimberly Hallie , Brown Jason R. , Schalper Kurt , Haack Herbert , Silver Matthew R. , Nixon Christian , Bossuyt Veerle , Pusztai Lajos , Lannin Donald R. , Rimm David L.
Published: April 2023

Supplemental Fig 1. Epithelial and stromal PD-L1 expression. Supplemental Fig 2. Validation of specificity of PD-L1 antibody used in this study. Supplemental Fig 3. Correlation with PD-L1 expression and pCR in patient subsets. Supplemental Fig 4. Joinpoint analysis of PD-L1 quantitative scores in the tumor mask (A) and stromal compartment (B). Supplemental Fig 5. Contingency tables of PD-L1 in the epithelium (A) and stroma (B) dichotomized by Joinpoint into low and high with pCR.
Supplementary Table 1 from Exposure to a Histone Deacetylase Inhibitor Has Detrimental Effects on Human Lymphocyte Viability and Function
Authors: Wong Deborah J.L. , Rao Amol , Avramis Earl , Matsunaga Douglas R. , Komatsubara Kimberly M. , Atefi Mohammad S. , Escuin-Ordinas Helena , Chodon Thinle , Koya Richard C. , Ribas Antoni , Comin-Anduix Begoña
Published: April 2023

PDF file - 26KB, Antibody Cocktails for Phosphoproteomic at single cell level.
Supplementary Figure 1 from Immunotherapy against Metastatic Melanoma with Human iPS Cell–Derived Myeloid Cell Lines Producing Type I Interferons
Authors: Miyashita Azusa , Fukushima Satoshi , Nakahara Satoshi , Kubo Yosuke , Tokuzumi Aki , Yamashita Junji , Aoi Jun , Haruta Miwa , Senju Satoru , Nishimura Yasuharu , Jinnin Masatoshi , Ihn Hironobu
Published: April 2023

We have conducted colony forming cells (CFC) assays to examine the ability of iPS-ML to proliferate and differentiate into colonies in a semi-solid media in response to cytokine stimulation. We found that human iPS-ML-IFN cells had colony forming capacity.
Supplementary Table S2 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Authors: Miller Lance D. , Chou Jeff A. , Black Michael A. , Print Cristin , Chifman Julia , Alistar Angela , Putti Thomas , Zhou Xiaobo , Bedognetti Davide , Hendrickx Wouter , Pullikuth Ashok , Rennhack Jonathan , Andrechek Eran R. , Demaria Sandra , Wang Ena , Marincola Francesco M.
Published: April 2023

Assessment of the prognostic significance of the IMM as a function of intrinsic subtype and proliferation tertile.
Supplementary Figure Legends from Intravesical BCG Induces CD4+ T-Cell Expansion in an Immune Competent Model of Bladder Cancer
Authors: Kates Max , Nirschl Thomas , Sopko Nikolai A. , Matsui Hotaka , Kochel Christina M. , Reis Leonardo O. , Netto George J. , Hoque Mohammad O. , Hahn Noah M. , McConkey David J. , Baras Alex S. , Drake Charles G. , Bivalacqua Trinity J.
Published: April 2023

Supplementary Figure Legends
Legend for Supplementary Figure 1 from IFNγ-Dependent Interactions between ICAM-1 and LFA-1 Counteract Prostaglandin E2–Mediated Inhibition of Antitumor CTL Responses
Authors: Basingab Fatemah Salem , Ahmadi Maryam , Morgan David John
Published: April 2023

Legend for Supplementary Figure 1
Supplementary Figure 2 from Estradiol Promotes Breast Cancer Cell Migration via Recruitment and Activation of Neutrophils
Authors: Vazquez Rodriguez Gabriela , Abrahamsson Annelie , Jensen Lasse Dahl Ejby , Dabrosin Charlotta
Published: April 2023

Validation of method for neutrophil infiltration into mammospheres
Supplementary Information - MIATA Checklist from Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers
Authors: Gross Stefanie , Lennerz Volker , Gallerani Elisa , Mach Nicolas , Böhm Steffen , Hess Dagmar , von Boehmer Lotta , Knuth Alexander , Ochsenbein Adrian , Gnad-Vogt Ulrike , Forssmann Ulf , Woelfel Thomas , Kaempgen Eckhart
Published: April 2023

Short peptide vaccine induces CD4+ T helper cells in patients with different solid cancers - desription of methods according to MIATA guidelines(MIATA checklist)
Supplementary Figure Legends from Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor–Modified T Cells
Authors: Berger Carolina , Sommermeyer Daniel , Hudecek Michael , Berger Michael , Balakrishnan Ashwini , Paszkiewicz Paulina J. , Kosasih Paula L. , Rader Christoph , Riddell Stanley R.
Published: April 2023

Supplementary Figure Legends
Supplemental Table 4 from Molecular Programming of Tumor-Infiltrating CD8+ T Cells and IL15 Resistance
Authors: Doedens Andrew L. , Rubinstein Mark P. , Gross Emilie T. , Best J. Adam , Craig David H. , Baker Megan K. , Cole David J. , Bui Jack D. , Goldrath Ananda W.
Published: April 2023

PyMT tumor CD8+ versus memory OT-I CD8+ gene expression and fold change.
Supplemental Figure S3 from Therapeutic Peptide Vaccine-Induced CD8 T Cells Strongly Modulate Intratumoral Macrophages Required for Tumor Regression
Authors: van der Sluis Tetje C. , Sluijter Marjolein , van Duikeren Suzanne , West Brian L. , Melief Cornelis J.M. , Arens Ramon , van der Burg Sjoerd H. , van Hall Thorbald
Published: April 2023

Tissue sections of spleen and liver were stained with the F4/80 macrophage marker. These photos are representative of the whole organ of two tested mice.
Supplementary Figure 1 from The Tumor Microenvironment Shapes Lineage, Transcriptional, and Functional Diversity of Infiltrating Myeloid Cells
Authors: Elpek Kutlu G. , Cremasco Viviana , Shen Hua , Harvey Christopher J. , Wucherpfennig Kai W. , Goldstein Daniel R. , Monach Paul A. , Turley Shannon J.
Published: April 2023

PDF file - 136K, Supplementary Figure S1: Additional figures on myeloid cell characterization in different tumor models.
Supplementary Tables 1 and 2 and Supplementary Figures 1 through 7 from Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia
Authors: Malaker Stacy A. , Penny Sarah A. , Steadman Lora G. , Myers Paisley T. , Loke Justin C. , Raghavan Manoj , Bai Dina L. , Shabanowitz Jeffrey , Hunt Donald F. , Cobbold Mark
Published: April 2023

Table S1. Summary of samples used for this study. Table S2. Antibodies used in the study. Figure S1. Mass spectra of all peptides referenced in figures 2 and 3. Figure S2. ETD Mass spectrum of RPPItQSSL containing an asymmetrically dimethylated Arg residue. Figure S3. ICS flow cytometry plots for HD5. Figure S4. Gating strategy for phenotyping shown in Fig 2E. Figure S5. Healthy donor immunity to O-GlcNAc peptides measured using IFNgamma ELISpot. Figure S6. ICS flow cytometry plots for HD5. Figure S7. Positional analysis of O-GlcNAc peptides.
Supplemental Table S1 from Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas
Authors: Long Adrienne H. , Highfill Steven L. , Cui Yongzhi , Smith Jillian P. , Walker Alec J. , Ramakrishna Sneha , El-Etriby Rana , Galli Susana , Tsokos Maria G. , Orentas Rimas J. , Mackall Crystal L.
Published: April 2023

GD2 expression on pediatric sarcomas
Supplementary Figures and Legends from Prostate Cancer Cells Express More Androgen Receptor (AR) Following Androgen Deprivation, Improving Recognition by AR-Specific T Cells
Authors: Olson Brian M. , Gamat Melissa , Seliski Joseph , Sawicki Thomas , Jeffery Justin , Ellis Leigh , Drake Charles G. , Weichert Jamey , McNeel Douglas G.
Published: April 2023

S1. Phenotypic validation of HLA-A2-transfected 22Rv1/FCS and 22Rv1/CSS cells. S2. AR-specific T cells obtained following peptide-immunization have increased recognition and lysis of androgen-deprived prostate tumor cells. S3. Immunization with pTVG-AR delays tumor growth, in a CD8-dependent fashion, in the presence or absence of ADT. S4. Immunization with pTVG-AR delays tumor growth in the presence or absence of ADT, and results in increased tumor-infiltrating T cells.
Supplementary Figures S1-S6 from Survivin Autoantibodies Are Not Elevated in Lung Cancer When Assayed Controlling for Specificity and Smoking Status
Authors: Broodman Ingrid , VanDuijn Martijn M. , Stingl Christoph , Dekker Lennard J.M. , Germenis Anastasios E. , de Koning Harry J. , van Klaveren Rob J. , Aerts Joachim G. , Lindemans Jan , Luider Theo M.
Published: April 2023

Supplementary Figure 1. Standard curve of rabbit monoclonal antibody to recombinant survivin using DAC-ELISA (A) and sandwich ELISA (B). Supplementary Figure 2. Antibody response to recombinant survivin was measured in seven NSCLC sera previously reported to be positive for survivin antibodies and in seven healthy non-smoking control sera. Supplementary Figure 3. Standard curve of rabbit anti-survivin spiked in non-smoking control sera using sandwich ELISA. Supplementary Figure 4. Standard curve of rabbit anti-survivin spiked in NSCLC patient sera using sandwich ELISA. Supplementary Figure 5. Standard curve of human autoantibodies to HuD using sandwich ELISA. Supplementary Figure 6. Results of sandwich ELISA were confirmed by western blot analysis.
Table S1 from IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release Capabilities
Authors: Dubois Sigrid , Conlon Kevin C. , Müller Jürgen R. , Hsu-Albert Jennifer , Beltran Nancy , Bryant Bonita R. , Waldmann Thomas A.
Published: April 2023

antibody table
Supplementary Movie S2 from Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8+ T Cells
Authors: Zahm Christopher D. , Colluru Viswa T. , McNeel Douglas G.
Published: April 2023

Representative video of OT-1 T cells interacting with SIINTEKL (FT) loaded APC.
Figure S3 from IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release Capabilities
Authors: Dubois Sigrid , Conlon Kevin C. , Müller Jürgen R. , Hsu-Albert Jennifer , Beltran Nancy , Bryant Bonita R. , Waldmann Thomas A.
Published: April 2023

Example of cytotoxicity assay. NK cell subsets were sorted by FACS. Control RAJI and target K562 cells were labeled with different CFSE concentrations, mixed and exposed to sorted NK cells for 18 hours. We determined the relative survival of control vs. target cells by FACS.
Supplementary Table 2 from Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors
Authors: Wang Qiong J. , Yu Zhiya , Griffith Kayla , Hanada Ken-ichi , Restifo Nicholas P. , Yang James C.
Published: April 2023

Supplementary Table 2: KRAS mutation status and HLA-A*11:01 expression of human pancreatic tumor lines used in the study.
Supplementary Materials and Methods, Supplementary Figure Legends, and Supplementary Table S1 from T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
Authors: Zah Eugenia , Lin Meng-Yin , Silva-Benedict Anne , Jensen Michael C. , Chen Yvonne Y.
Published: April 2023

Supplementary Materials and Methods, Supplementary Figure Legends, and Supplementary Table S1 (primers for cloning of bi-specific CARs)
Supplementary Figure S5 from Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20
Authors: Weiskopf Kipp , Anderson Katie L. , Ito Daisuke , Schnorr Peter J. , Tomiyasu Hirotaka , Ring Aaron M. , Bloink Kristin , Efe Jem , Rue Sarah , Lowery David , Barkal Amira , Prohaska Susan , McKenna Kelly M. , Cornax Ingrid , O'Brien Timothy D. , O'Sullivan M. Gerard , Weissman Irving L. , Modiano Jaime F.
Published: April 2023

1E4 antibody binds canine CD20 extracellular domain 2.
Supplementary Figure Legends from Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
Authors: da Silva Ines Pires , Gallois Anne , Jimenez-Baranda Sonia , Khan Shaukat , Anderson Ana C. , Kuchroo Vijay K. , Osman Iman , Bhardwaj Nina
Published: April 2023

PDF file - 100K
Supplementary Figure 1 from PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection
Authors: MacFarlane Alexander W. , Jillab Mowafaq , Plimack Elizabeth R. , Hudes Gary R. , Uzzo Robert G. , Litwin Samuel , Dulaimi Essel , Al-Saleem Tahseen , Campbell Kerry S.
Published: April 2023

PDF file - 4006K, Myeloid cell gating strategy. The myeloid cell gating strategy used in these experiments is shown with representative data from a healthy control donor. A. Forward scatter area and height were used to exclude aggregates and clusters of cells. B. Dead cells were excluded by propidium iodode staining. C. CD45+ Leukocytes were divided into lymphocyte and myeloid gates based on side scatter. D. T cells and NK cells were excluded from the myeloid cell analysis by CD3 and CD56 expression. E. Cells that express neither CD14 nor CD16 were excluded from the myeloid analysis (mostly B cells at this point in the gating). F. Myeloid cells were sub-gated into Classical Monocytes (CD14bright CD16-), Intermediate Monocytes (CD14bright CD16dim), Non-classical Monocytes (CD14dim CD16dim), CD14bright CD16bright myeloid cells, and Neutrophils (CD14dim CD16bright). Note that most of the neutrophils were removed along with the erythrocytes during gradient centrifugation on Lympoprep).
Supplementary Figure Legends from Virotherapy with a Semliki Forest Virus–Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade
Authors: Quetglas José I. , Labiano Sara , Aznar M. Ángela , Bolaños Elixabet , Azpilikueta Arantza , Rodriguez Inmaculada , Casales Erkuden , Sánchez-Paulete Alfonso R. , Segura Víctor , Smerdou Cristian , Melero Ignacio
Published: April 2023

Supplementary figure legends
Supplemental Figure 3: from Cross-talk between 4-1BB and TLR1–TLR2 Signaling in CD8+ T Cells Regulates TLR2′s Costimulatory Effects
Authors: Joseph Ann Mary , Srivastava Ratika , Zabaleta Jovanny , Davila Eduardo
Published: April 2023

Combination of TLR and 4-1BB stimulation on CD8+ T cells has little additive effect on the expression of apoptosis regulators but is dependent on cIAP1/2 function.
Supplementary Movie 2 from Individual Motile CD4+ T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells
Authors: Liadi Ivan , Singh Harjeet , Romain Gabrielle , Rey-Villamizar Nicolas , Merouane Amine , Adolacion Jay R T. , Kebriaei Partow , Huls Helen , Qiu Peng , Roysam Badrinath , Cooper Laurence J.N. , Varadarajan Navin
Published: April 2023

Movie M2. Representative example of a CAR8 cell from the S2 subgroup.
Supplementary Movie 1 from Individual Motile CD4+ T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells
Authors: Liadi Ivan , Singh Harjeet , Romain Gabrielle , Rey-Villamizar Nicolas , Merouane Amine , Adolacion Jay R T. , Kebriaei Partow , Huls Helen , Qiu Peng , Roysam Badrinath , Cooper Laurence J.N. , Varadarajan Navin
Published: April 2023

Movie M1. Representative example of a CAR8 cell from the S1 subgroup.
Table S2 from Comprehensive Immune Profiling of Lung Adenocarcinomas Reveals Four Immunosubtypes with Plasma Cell Subtype a Negative Indicator
Authors: Kurebayashi Yutaka , Emoto Katsura , Hayashi Yuichiro , Kamiyama Ikuo , Ohtsuka Takashi , Asamura Hisao , Sakamoto Michiie
Published: April 2023

Multivariate analysis of clinicopathological factors and infiltrating immune cells
Supplementary Figure 2 from Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC
Authors: Tumeh Paul C. , Hellmann Matthew D. , Hamid Omid , Tsai Katy K. , Loo Kimberly L. , Gubens Matthew A. , Rosenblum Michael , Harview Christina L. , Taube Janis M. , Handley Nathan , Khurana Neharika , Nosrati Adi , Krummel Matthew F. , Tucker Andrew , Sosa Eduardo V. , Sanchez Phillip J. , Banayan Nooriel , Osorio Juan C. , Nguyen-Kim Dan L. , Chang Jeremy , Shintaku I. Peter , Boasberg Peter D. , Taylor Emma J. , Munster Pamela N. , Algazi Alain P. , Chmielowski Bartosz , Dummer Reinhard , Grogan Tristan R. , Elashoff David , Hwang Jimmy , Goldinger Simone M. , Garon Edward B. , Pierce Robert H. , Daud Adil
Published: April 2023

Quantitative CD8+ Counts in patients with Liver and skin metastases.
Supplementary figure legends from Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells
Authors: Homet Moreno Blanca , Zaretsky Jesse M. , Garcia-Diaz Angel , Tsoi Jennifer , Parisi Giulia , Robert Lidia , Meeth Katrina , Ndoye Abibatou , Bosenberg Marcus , Weeraratna Ashani T. , Graeber Thomas G. , Comin-Anduix Begoña , Hu-Lieskovan Siwen , Ribas Antoni
Published: April 2023

Supplementary figure legends
Supplemental Tables 1 through 4 and Supplemental Figures 1 and 2 from Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients
Authors: Tada Kohei , Kitano Shigehisa , Shoji Hirokazu , Nishimura Takashi , Shimada Yasuhiro , Nagashima Kengo , Aoki Kazunori , Hiraoka Nobuyoshi , Honma Yoshitaka , Iwasa Satoru , Okita Natsuko , Takashima Atsuo , Kato Ken , Yamada Yasuhide , Katayama Naoyuki , Boku Narikazu , Heike Yuji , Hamaguchi Tetsuya
Published: April 2023

Supplemental Table 1 Combined assessment of quantities of two values from among M-MDSC, CD4+ TEM, and CD8+ TEM cells for correlation with PFS Supplemental Table 2 Comparison of patient characteristics between Group 1/2 and Group 3/4 Supplemental Table 3 Univariate analysis of the covariates patient characteristics and cytokines for PFS Supplemental Table 4 Comparisons of 10 cytokine concentrations in plasma between Group 1/2 and Group 3/4 Supplemental Figure 1 (A) Gating strategy and representative dot plots for G-MDSCs, DC (B) Gating strategy and representative dot plots for Treg, NK, Granzyme B+, Perforin+ and Ki-67+ cells Supplemental Figure 2 (A) Change in each immune cell type over time (B) Kaplan-Meier curves for PFS of patients who showed an increase or decrease in immune cells
Supplementary Figure 2 from Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells
Authors: Homet Moreno Blanca , Zaretsky Jesse M. , Garcia-Diaz Angel , Tsoi Jennifer , Parisi Giulia , Robert Lidia , Meeth Katrina , Ndoye Abibatou , Bosenberg Marcus , Weeraratna Ashani T. , Graeber Thomas G. , Comin-Anduix Begoña , Hu-Lieskovan Siwen , Ribas Antoni
Published: April 2023

Quantification of CD3+CD8+ (CD8 T-cells) and (B) CD3+CD4+ (CD4 T-cells) in both tumors and spleens in YUMM2.1; gating strategy after exclusion of dead cells of CD3+CD8+ and CD3+CD4+ cells after gating for CD3+ cells; quantification of CD3+CD8+ (CD8 T-cells) in MC38 and YUMM2.1 spleens; CD3+CD4+ (CD4 T-cells) in MC38 and YUMM 2.1 spleens CD8 T-cells in both tumors and spleens in YUMM1.1.
Supplemental Figure 2 from Afucosylated Antibodies Increase Activation of FcγRIIIa-Dependent Signaling Components to Intensify Processes Promoting ADCC
Authors: Liu Scot D. , Chalouni Cecile , Young Judy C. , Junttila Teemu T. , Sliwkowski Mark X. , Lowe John B.
Published: April 2023

Approximates the amount of fucosylated antibody required to elicit similar protein tyrosine phosphorylation signaling compared to afucosylated antibodies.
Supplementary Movie 1 from Committing Cytomegalovirus-Specific CD8 T Cells to Eliminate Tumor Cells by Bifunctional Major Histocompatibility Class I Antibody Fusion Molecules
Authors: Schmittnaegel Martina , Levitsky Victor , Hoffmann Eike , Georges Guy , Mundigl Olaf , Klein Christian , Knoetgen Hendrik
Published: April 2023

Time-lapse fluorescence microscopy of CMV-pp65-specific T cell mediated killing of MCSP+ tumor cells (Colo38) incubated with 15nM of CMV-pMHCI-IgG. Constructs are indicated in the respective panel. T cells are stained in red (PKH-26, Sigma), tumor cells in green (CMFDA, LifeTechnologies). Effector to target ratio was 3:1. Real-time is indicated in the lower left corner in h:m:s:ms (h=hours, m=minutes, s=seconds, ms=milliseconds), scale bar is shown in the lower right corner 0-50 µm (µm=micrometre).
Supplementary Figure 2 from Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti–PD-L1 Immune Checkpoint Inhibitor
Authors: Vandeveer Amanda J. , Fallon Jonathan K. , Tighe Robert , Sabzevari Helen , Schlom Jeffrey , Greiner John W.
Published: April 2023

Biological and immunologic characteristics of anti-PD-L1.
Supplementary Movie 2 from CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells
Authors: Davenport Alexander J. , Jenkins Misty R. , Cross Ryan S. , Yong Carmen S. , Prince H. Miles , Ritchie David S. , Trapani Joseph A. , Kershaw Michael H. , Darcy Phillip K. , Neeson Paul J.
Published: April 2023

Movie 2. CAR.OT-I cells co-cultured with MC57-OVA257 cells.
Supplementary Figures 1 - 7 from B7-H4 Expression by Nonhematopoietic Cells in the Tumor Microenvironment Promotes Antitumor Immunity
Authors: Rahbar Ramtin , Lin Albert , Ghazarian Magar , Yau Helen-Loo , Paramathas Sangeetha , Lang Philipp A. , Schildknecht Anita , Elford Alisha R. , Garcia-Batres Carlos , Martin Bernard , Berman Hal K. , Leong Wey L. , McCready David R. , Reedijk Michael , Done Susan J. , Miller Naomi , Youngson Bruce , Suh Woong-Kyung , Mak Tak W. , Ohashi Pamela S.
Published: April 2023

Supplementary Figure 1. B7-H4 expression promotes survival of tumor bearing mice. Supplementary Figure 2. LCMV-gp is expressed during lactation and detectable by gp-specific T cells. Supplementary Figure 3. LCMV infection inhibits tumor growth in WAP-gp/MMTV-PyMT mice. Supplementary Figure 4. Expression of LCMV-gp does not alter tumor growth. Supplementary Figure 5. B7-H4 negatively regulates LCMV-induced T cell responses. Supplementary Figure 6. B7-H4 plays a positive role in anti-tumor immunity. Supplementary Figure 7. B7-H4 expression correlates with MHC-I expression in human breast cancer samples.
Supplementary Figure Legends from IL17A-Mediated Endothelial Breach Promotes Metastasis Formation
Authors: Kulig Paulina , Burkhard Sara , Mikita-Geoffroy Joanna , Croxford Andrew L. , Hövelmeyer Nadine , Gyülvészi Gabor , Gorzelanny Christian , Waisman Ari , Borsig Lubor , Becher Burkhard
Published: April 2023

Supplementary Figure Legends
Supplementary Table 1 from Squamous Cell Tumors Recruit γδ T Cells Producing either IL17 or IFNγ Depending on the Tumor Stage
Authors: Lo Presti Elena , Toia Francesca , Oieni Sebastiano , Buccheri Simona , Turdo Alice , Mangiapane Laura Rosa , Campisi Giuseppina , Caputo Valentina , Todaro Matilde , Stassi Giorgio , Cordova Adriana , Moschella Francesco , Rinaldi Gaetana , Meraviglia Serena , Dieli Francesco
Published: April 2023

Characteristics of patients
Supplementary methods from Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status
Authors: Roemer Margaretha G.M. , Advani Ranjana H. , Redd Robert A. , Pinkus Geraldine S. , Natkunam Yasodha , Ligon Azra H. , Connelly Courtney F. , Pak Christine J. , Carey Christopher D. , Daadi Sarah E. , Chapuy Bjoern , de Jong Daphne , Hoppe Richard T. , Neuberg Donna S. , Shipp Margaret A. , Rodig Scott J.
Published: April 2023

Supplementary methods
Supplementary Table 1 from Myelodysplastic Syndrome Revealed by Systems Immunology in a Melanoma Patient Undergoing Anti–PD-1 Therapy
Authors: Greenplate Allison R. , Johnson Douglas B. , Roussel Mikael , Savona Michael R. , Sosman Jeffrey A. , Puzanov Igor , Ferrell P. Brent , Irish Jonathan M.
Published: April 2023

Mass cytometry panel of antibodies.
Supplementary Figure 1 from Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment Efficacy
Authors: Trotta Anna Maria , Ottaiano Alessandro , Romano Carmela , Nasti Guglielmo , Nappi Anna , De Divitiis Chiara , Napolitano Maria , Zanotta Serena , Casaretti Rossana , D'Alterio Crescenzo , Avallone Antonio , Califano Daniela , Iaffaioli Rosario Vincenzo , Scala Stefania
Published: April 2023

Bland-Altman plot % increase in cetuximab-mediated ADCC: difference SRB assay-Cytotox96 vs average. By plotting the difference between the % ADCC increase determined by each of the methods against the mean of the two determinations it is possible to determine the concordance between both methods. The limits of agreement are also calculated to give a quantitative analysis of the differences between both methods.
Supplementary Tables 1 - 4, Figures 1 - 2 from Peptide/MHC Tetramer–Based Sorting of CD8+ T Cells to a Leukemia Antigen Yields Clonotypes Drawn Nonspecifically from an Underlying Restricted Repertoire
Authors: Hunsucker Sally A. , McGary Colleen S. , Vincent Benjamin G. , Enyenihi Atim A. , Waugh Jennifer P. , McKinnon Karen P. , Bixby Lisa M. , Ropp Patricia A. , Coghill James M. , Wood William A. , Gabriel Don A. , Sarantopoulos Stefanie , Shea Thomas C. , Serody Jonathan S. , Alatrash Gheath , Rodriguez-Cruz Tania , Lizée Gregory , Buntzman Adam S. , Frelinger Jeffrey A. , Glish Gary L. , Armistead Paul M.
Published: April 2023

The document contains 4 supplemental tables: 1. RT-PCR Primers for TCRbeta sequencing 2. HPLC-MS identified peptide sequences 3. The amino acid sequences of recurrent TCRbeta clonotypes 4. The distribution of the CDR3 amino acid length in the analyzed patient. There are 2 supplementary figures: 1. Tetramer flow cytometry showing the generation of an oligoclonal T-cell population with a UNC-CDK4-1 high affinity T-cell population. 2. More detailed information regarding the tetramer gating strategy employed.
Supplementary Figure S5 from Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib
Authors: Frazao Alexandra , Colombo Marina , Fourmentraux-Neves Emmanuelle , Messaoudene Meriem , Rusakiewicz Sylvie , Zitvogel Laurence , Vivier Eric , Vély Frédéric , Faure Florence , Dréno Brigitte , Benlalam Houssem , Bouquet Fanny , Savina Ariel , Pasmant Eric , Toubert Antoine , Avril Marie-Françoise , Caignard Anne
Published: April 2023

Effect of Vemurafenib on BRAF non mutated melanoma cell lines
Supplementary Figure 3 from The Promotion of Breast Cancer Metastasis Caused by Inhibition of CSF-1R/CSF-1 Signaling Is Blocked by Targeting the G-CSF Receptor
Authors: Swierczak Agnieszka , Cook Andrew D. , Lenzo Jason C. , Restall Christina M. , Doherty Judy P. , Anderson Robin L. , Hamilton John A.
Published: April 2023

PDF file - 56K, Supplementary Figure 3: Images of lungs from mice bearing 4T1.2 or 67NR tumors.
Supplemental Table 2 from Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib
Authors: Frazao Alexandra , Colombo Marina , Fourmentraux-Neves Emmanuelle , Messaoudene Meriem , Rusakiewicz Sylvie , Zitvogel Laurence , Vivier Eric , Vély Frédéric , Faure Florence , Dréno Brigitte , Benlalam Houssem , Bouquet Fanny , Savina Ariel , Pasmant Eric , Toubert Antoine , Avril Marie-Françoise , Caignard Anne
Published: April 2023

Summary of analyzed NK receptors.
Supplementary Figure 1 from The Promotion of Breast Cancer Metastasis Caused by Inhibition of CSF-1R/CSF-1 Signaling Is Blocked by Targeting the G-CSF Receptor
Authors: Swierczak Agnieszka , Cook Andrew D. , Lenzo Jason C. , Restall Christina M. , Doherty Judy P. , Anderson Robin L. , Hamilton John A.
Published: April 2023

PDF file - 1316K, Supplementary Figure 1: Flow cytometric analysis of neutrophils and macrophage sub-populations.
Supplementary Figure 1 from Complement Factor H Antibodies from Lung Cancer Patients Induce Complement-Dependent Lysis of Tumor Cells, Suggesting a Novel Immunotherapeutic Strategy
Authors: Campa Michael J. , Gottlin Elizabeth B. , Bushey Ryan T. , Patz Edward F.
Published: April 2023

Domain mapping of CFH autoantibody.
Supplementary Figure 2 from Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141+ Dendritic Cells and Enhanced Cross-Presentation
Authors: Sluijter Berbel J.R. , van den Hout Mari F.C.M. , Koster Bas D. , van Leeuwen Paul A.M. , Schneiders Famke L. , van de Ven Rieneke , Molenkamp Barbara G. , Vosslamber Saskia , Verweij Cornelis L. , van den Tol M. Petrousjka , van den Eertwegh Alfons J.M. , Scheper Rik J. , de Gruijl Tanja D.
Published: April 2023

Expression of the cross-priming associated markers BDCA3/CD141 and CLEC9A on the four identified cDC subsets in single-cell suspensions of untreated melanoma Sentinel Lymph Nodes SLN (mean {plus minus} SEM of at least three separate experiments are shown).
Supplemental Tables 1 - 2, Figures 1 - 3 from Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma
Authors: Jensen Jeffrey Lee , Rakhmilevich Alexander , Heninger Erika , Broman Aimee Teo , Hope Chelsea , Phan Funita , Miyamoto Shigeki , Maroulakou Ioanna , Callander Natalie , Hematti Peiman , Chesi Marta , Bergsagel P. Leif , Sondel Paul , Asimakopoulos Fotis
Published: April 2023

Supplementary Table S1. Cox proportional hazards results for overall survival. Supplementary Table S2. Cox proportional hazards results for progression-free survival. Supplementary Figure S1. alphaCD40+TLR-activated macrophages induce myeloma cell demise through apoptosis ex vivo. Supplementary Figure S2. Levels of inflammatory cytokines IL1Beta and IL6 in the serum of myeloma-bearing animals following alphaCD40+CpG treatment. Supplementary Figure S3. Vk12598 myeloma cells express low-detectable amounts of surface CD40.
Supplemental Figure S2 from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
Authors: Moskalenko Marina , Pan Michael , Fu Yichun , de Moll Ellen H. , Hashimoto Daigo , Mortha Arthur , Leboeuf Marylene , Jayaraman Padmini , Bernardo Sebastian , Sikora Andrew G. , Wolchok Jedd , Bhardwaj Nina , Merad Miriam , Saenger Yvonne
Published: April 2023

Depletion of NKp46+ (A), CD90+ (B), and CD8+ (C) cells.Gating strategy to identify macrophage and MDSC populations.
Supplemental Figure S1 from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
Authors: Moskalenko Marina , Pan Michael , Fu Yichun , de Moll Ellen H. , Hashimoto Daigo , Mortha Arthur , Leboeuf Marylene , Jayaraman Padmini , Bernardo Sebastian , Sikora Andrew G. , Wolchok Jedd , Bhardwaj Nina , Merad Miriam , Saenger Yvonne
Published: April 2023

Therapeutic efficacy of αTRP1 combined with two doses of cyclophosphamide (CY) in established melanoma.
Supplemental Figure 1 from Mutant KRAS Conversion of Conventional T Cells into Regulatory T Cells
Authors: Zdanov Stephanie , Mandapathil Magis , Abu Eid Rasha , Adamson-Fadeyi Saudat , Wilson Willie , Qian Jiahua , Carnie Andrea , Tarasova Nadya , Mkrtichyan Mikayel , Berzofsky Jay A. , Whiteside Theresa L. , Khleif Samir N.
Published: April 2023

Supplemental Figure 1: (A) mRNA level of Kras in wild-type Kras tumor cells (Colo320) overexpressing mutant KrasG12V plasmid (Kras Pd) is significantly higher than cells with a mock plasmid. (B) Representative dot plots showing that the percentage of IL-10+ and TGF-beta1+, CTLA-4+ and CD122+ T-lymphocytes co-cultured with wild-type Kras tumor cells (Colo320) overexpressing mutant KrasG12V plasmid (Kras Pd) is significantly higher than WT-cells.
Supplementary Table 2 from The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer
Authors: Miyamoto Sho , Kochin Vitaly , Kanaseki Takayuki , Hongo Ayumi , Tokita Serina , Kikuchi Yasuhiro , Takaya Akari , Hirohashi Yoshihiko , Tsukahara Tomohide , Terui Takeshi , Ishitani Kunihiko , Hata Fumitake , Takemasa Ichiro , Miyazaki Akihiro , Hiratsuka Hiroyoshi , Sato Noriyuki , Torigoe Toshihiko
Published: April 2023

Summary of clinical annotations, HLA types, and the results of IV9-CTL induction in six CRC patients.
Supplementary figure legends from Nanoparticle Conjugation of Human Papillomavirus 16 E7-long Peptides Enhances Therapeutic Vaccine Efficacy against Solid Tumors in Mice
Authors: Galliverti Gabriele , Tichet Mélanie , Domingos-Pereira Sonia , Hauert Sylvie , Nardelli-Haefliger Denise , Swartz Melody A. , Hanahan Douglas , Wullschleger Stephan
Published: April 2023

This file contains the figure legends relative to all the supplementary figures.
Supplementary Table 1 from The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer
Authors: Miyamoto Sho , Kochin Vitaly , Kanaseki Takayuki , Hongo Ayumi , Tokita Serina , Kikuchi Yasuhiro , Takaya Akari , Hirohashi Yoshihiko , Tsukahara Tomohide , Terui Takeshi , Ishitani Kunihiko , Hata Fumitake , Takemasa Ichiro , Miyazaki Akihiro , Hiratsuka Hiroyoshi , Sato Noriyuki , Torigoe Toshihiko
Published: April 2023

A list of HLA-A24 peptides displayed by SP-H and MP-A.
Supplementary Table 1 from Exosomes Associated with Human Ovarian Tumors Harbor a Reversible Checkpoint of T-cell Responses
Authors: Shenoy Gautam N. , Loyall Jenni , Maguire Orla , Iyer Vandana , Kelleher Raymond J. , Minderman Hans , Wallace Paul K. , Odunsi Kunle , Balu-Iyer Sathy V. , Bankert Richard B.
Published: April 2023

List of reagents used in flow cytometry and fluorescence microscopy
Supplementary Figures 1-8 from The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer
Authors: Miyamoto Sho , Kochin Vitaly , Kanaseki Takayuki , Hongo Ayumi , Tokita Serina , Kikuchi Yasuhiro , Takaya Akari , Hirohashi Yoshihiko , Tsukahara Tomohide , Terui Takeshi , Ishitani Kunihiko , Hata Fumitake , Takemasa Ichiro , Miyazaki Akihiro , Hiratsuka Hiroyoshi , Sato Noriyuki , Torigoe Toshihiko
Published: April 2023

S1. The surface HLA class I levels on SP and MP clones. S2. ASB4 gene expression is scarce in normal tissues but frequent in CRC tissues. S3. Enrichment of ASB4 gene expression by sphere culture of CRC cell lines. S4. Unsorted SW480 is composed of 1-2% of SP and the other MP cells. S5. SM4 recognized and lyses HCT15 as well as SP-H. S6. Selection of a control CTL clone that does respond to IV9-HLA-A24 complexes. S7. In vivo CTL infiltration into tumor lesions. S8. Silencing ASB4 gene expression does not necessarily result in loss of sphere- and tumor-forming ability in SP-H.
Figure S2 from Sustained Type I Interferon Reinforces NK Cell–Mediated Cancer Immunosurveillance during Chronic Virus Infection
Authors: Oh Ji Hoon , Kim Myeong Joon , Choi Seong Jin , Ban Young Ho , Lee Heung Kyu , Shin Eui-Cheol , Lee Kyung-Mi , Ha Sang-Jun
Published: April 2023

Figure S2. shows the IFN-γ production of NK cells stimulated by cytokines.
Video 5 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
Authors: Gui Philippe , Ben-Neji Myriam , Belozertseva Ekaterina , Dalenc Florence , Franchet Camille , Gilhodes Julia , Labrousse Arnaud , Bellard Elisabeth , Golzio Muriel , Poincloux Renaud , Maridonneau-Parini Isabelle , Le Cabec Véronique
Published: April 2023

Video 5
Video 2 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
Authors: Gui Philippe , Ben-Neji Myriam , Belozertseva Ekaterina , Dalenc Florence , Franchet Camille , Gilhodes Julia , Labrousse Arnaud , Bellard Elisabeth , Golzio Muriel , Poincloux Renaud , Maridonneau-Parini Isabelle , Le Cabec Véronique
Published: April 2023

Video 2
Supplementary Data from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
Authors: Gui Philippe , Ben-Neji Myriam , Belozertseva Ekaterina , Dalenc Florence , Franchet Camille , Gilhodes Julia , Labrousse Arnaud , Bellard Elisabeth , Golzio Muriel , Poincloux Renaud , Maridonneau-Parini Isabelle , Le Cabec Véronique
Published: April 2023

legend of supplementary figures
Supplementary Figure S5 from PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients
Authors: Concha-Benavente Fernando , Kansy Benjamin , Moskovitz Jessica , Moy Jennifer , Chandran Uma , Ferris Robert L.
Published: April 2023

Supplementary Figure S5
Supplementary Figure 2 from IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer
Authors: Mirlekar Bhalchandra , Michaud Daniel , Searcy Ryan , Greene Kevin , Pylayeva-Gupta Yuliya
Published: April 2023

This figure demonstrates that infiltrating immune cells contain low amounts of cytokines IL12 and IL27
Supplementary Table 1 from The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade
Authors: Li Howard Y. , McSharry Maria , Bullock Bonnie , Nguyen Teresa T. , Kwak Jeff , Poczobutt Joanna M. , Sippel Trisha R. , Heasley Lynn E. , Weiser-Evans Mary C. , Clambey Eric T. , Nemenoff Raphael A.
Published: April 2023

List of Antibodies Used for Flow Cytometry
Supplementary Figure 7 from The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade
Authors: Li Howard Y. , McSharry Maria , Bullock Bonnie , Nguyen Teresa T. , Kwak Jeff , Poczobutt Joanna M. , Sippel Trisha R. , Heasley Lynn E. , Weiser-Evans Mary C. , Clambey Eric T. , Nemenoff Raphael A.
Published: April 2023

Heatmap of cytokines that were expressed >5-fold higher in CMT167 cells in vivo compared to LLC cells in vivo
Supplementary Figure 5 from YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
Authors: Kim Min Hwan , Kim Chang Gon , Kim Sang-Kyum , Shin Sang Joon , Choe Eun Ah , Park Su-Hyung , Shin Eui-Cheol , Kim Joon
Published: April 2023

S5. Cytotoxicity assay of A375SM cells co-cultured with Melan-A26-35-specific CD8+ T cells.
Supplementary Figures and Table S1 from Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations
Authors: Veatch Joshua R. , Jesernig Brenda L. , Kargl Julia , Fitzgibbon Matthew , Lee Sylvia M. , Baik Christina , Martins Renato , Houghton A. McGarry , Riddell Stanley R.
Published: April 2023

Supplementary Figures and Table S1
Figure S1 from NK Cells Control Tumor-Promoting Function of Neutrophils in Mice
Authors: Ogura Keisuke , Sato-Matsushita Marimo , Yamamoto Seiji , Hori Takashi , Sasahara Masakiyo , Iwakura Yoichiro , Saiki Ikuo , Tahara Hideaki , Hayakawa Yoshihiro
Published: April 2023

Supplementary Figure 1. Characterization of MCA205-Luc2 cells.
Supplementary tables and figures from Clonal Expansion and Interrelatedness of Distinct B-Lineage Compartments in Multiple Myeloma Bone Marrow
Authors: Hansmann Leo , Han Arnold , Penter Livius , Liedtke Michaela , Davis Mark M.
Published: April 2023

Table S1: Patient characteristics Table S2: Cell culture medium Table S3: FACS reagents Table S4A: Primers for RT PCR and amplification Table S4B: DNA barcodes Table S5: Immunoglobulin junction sequences that were detected in at least two cells per sample Figure S1: Figure S1: Gating strategy for single-cell index sorting and t-SNE visualization. Figure S2: Definition of background reads and cut-offs. Figure S3: Fluorescence data revealed from index sorting is highly accurate. Figure S4: Sequence logos of the nucleotide sequences of the predominant clones. Figure S5: Immune phenotypes of the predominant clones. Figure S6: Detailed phenotypes of major less predominant clones in all three multiple myeloma samples. Figure S7: Alignment of the light chain nucleotide sequences of the predominant clone in the peripheral blood of a healthy individual.
Supplementary Table 3 from Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic Cells
Authors: Fragale Alessandra , Romagnoli Giulia , Licursi Valerio , Buoncervello Maria , Del Vecchio Giorgia , Giuliani Caterina , Parlato Stefania , Leone Celeste , De Angelis Marta , Canini Irene , Toschi Elena , Belardelli Filippo , Negri Rodolfo , Capone Imerio , Presutti Carlo , Gabriele Lucia
Published: April 2023

Supplementary Table 3 is an Excell file containig a list of genes that shown ARI-induced modifications referred with ID, symbol, gene name, fold, p.value, by ChIP-seq with H3K9me2 antibody.
Suppl Figure 3 from Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma
Authors: Solomon Benjamin , Young Richard J. , Bressel Mathias , Urban Damien , Hendry Shona , Thai Alesha , Angel Christopher , Haddad Afaf , Kowanetz Marcin , Fua Tsien , Corry June , Fox Stephen , Rischin Danny
Published: April 2023

Consort diagram
Figure S5 from Macrophages and CD8+ T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors
Authors: Zhang Jennifer Q. , Zeng Shan , Vitiello Gerardo A. , Seifert Adrian M. , Medina Benjamin D. , Beckman Michael J. , Loo Jennifer K. , Santamaria-Barria Juan , Maltbaek Joanna H. , Param Nesteene J. , Moral John A. , Zhao Julia N. , Balachandran Vinod , Rossi Ferdinand , Antonescu Cristina R. , DeMatteo Ronald P.
Published: April 2023

CD45
Figure S3 from Macrophages and CD8+ T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors
Authors: Zhang Jennifer Q. , Zeng Shan , Vitiello Gerardo A. , Seifert Adrian M. , Medina Benjamin D. , Beckman Michael J. , Loo Jennifer K. , Santamaria-Barria Juan , Maltbaek Joanna H. , Param Nesteene J. , Moral John A. , Zhao Julia N. , Balachandran Vinod , Rossi Ferdinand , Antonescu Cristina R. , DeMatteo Ronald P.
Published: April 2023

Monocytes and DCs
Supplementary Figure 5 from Drug-Induced Senescent Multiple Myeloma Cells Elicit NK Cell Proliferation by Direct or Exosome-Mediated IL15 Trans-Presentation
Authors: Borrelli Cristiana , Ricci Biancamaria , Vulpis Elisabetta , Fionda Cinzia , Ricciardi Maria Rosaria , Petrucci Maria Teresa , Masuelli Laura , Peri Agnese , Cippitelli Marco , Zingoni Alessandra , Santoni Angela , Soriani Alessandra
Published: April 2023

Fig S5. MEL-treated SKO-007(J3) and ARK exosomes display a similar IL-15RA expression.
Supplementary Figure 3 from Drug-Induced Senescent Multiple Myeloma Cells Elicit NK Cell Proliferation by Direct or Exosome-Mediated IL15 Trans-Presentation
Authors: Borrelli Cristiana , Ricci Biancamaria , Vulpis Elisabetta , Fionda Cinzia , Ricciardi Maria Rosaria , Petrucci Maria Teresa , Masuelli Laura , Peri Agnese , Cippitelli Marco , Zingoni Alessandra , Santoni Angela , Soriani Alessandra
Published: April 2023

Figure S3. MEL-treated MM cells induce NK cells entry in the S phase of the cell cycle.
Supplementary Figure S4 from Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance
Authors: Hennequart Marc , Pilotte Luc , Cane Stefania , Hoffmann Delia , Stroobant Vincent , Plaen Etienne De , Eynde Benoît J. Van den
Published: April 2023

Quantification of EP receptors and PGE2 production in different cancer cell lines.
Supplementary Figure Legends from Automated Analysis of Lymphocytic Infiltration, Tumor Budding, and Their Spatial Relationship Improves Prognostic Accuracy in Colorectal Cancer
Authors: Nearchou Ines P. , Lillard Kate , Gavriel Christos G. , Ueno Hideki , Harrison David J. , Caie Peter D.
Published: April 2023

Supplementary Figure Legends
Supplementary Figure 2 from Automated Analysis of Lymphocytic Infiltration, Tumor Budding, and Their Spatial Relationship Improves Prognostic Accuracy in Colorectal Cancer
Authors: Nearchou Ines P. , Lillard Kate , Gavriel Christos G. , Ueno Hideki , Harrison David J. , Caie Peter D.
Published: April 2023

Supplementary Figure 2. ROC curves for pT stage Immunoscore and the components of the Tumor Bud-Immuno Spastial Index for the training cohort.
Supplemental Data from Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell–Effector Responses
Authors: Clancy-Thompson Eleanor , Devlin Christine A. , Tyler Paul M. , Servos Mariah M. , Ali Lestat R. , Ventre Katherine S. , Bhuiyan M. Aladdin , Bruck Patrick T. , Birnbaum Michael E. , Dougan Stephanie K.
Published: April 2023

Supplemental Table and Figures S1 and S2